DiscoveryPak Receptor Tyrosine Kinase (RTK) Inhibitor Set

Catalog number
K859-8
Name
DiscoveryPak Receptor Tyrosine Kinase (RTK) Inhibitor Set
Size
8 inhibitors
Price
820.00 EUR
Supplier

Details

Alternate Name/Synonyms
Receptor Tyrosine Kinase (RTK) Inhibitor Set, DiscoveryPak
Appearance
Lyophilized solids
Formulation
N/A
CAS Number
See under the individual product
Peptide sequence
N/A
Molecular Formula
See under the individual product
Molecular Weight
See under the individual product
Purity
≥95% by HPLC
Solubility/Reconstitution Instructions
DMSO
Handling
Protect from air, light and moisture
Tagline
A Receptor Tyrosine Kinase (RTK) inhibitors panel
Storage Temp.
-20°C
Shipping Conditions
gel pack
Shelf Life
24 months
MDL Number
N/A
PubChem CID
N/A
Category
Biochemicals
Description
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.The receptors are ligand binding factors of type 1, 2 or 3 and protein-molecules that receive chemical-signals from outside a cell. When such chemical-signals couple or bind to a receptor, they cause some form of cellular/tissue-response, e.g. a change in the electrical-activity of a cell. In this sense, am olfactory receptor is a protein-molecule that recognizes and responds to endogenous-chemical signals, chemokinesor cytokines e.g. an acetylcholine-receptor recognizes and responds to its endogenous-ligand, acetylcholine. However, sometimes in pharmacology, the term is also used to include other proteins that are drug-targets, such as enzymes, transporters and ion-channels.